Axogen, Inc. Promotes Peter J. Mariani to Government Vice President and Chief Economical Officer Nasdaq:AXGN

ALACHUA, Fla., March 01, 2021 (Globe NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a international leader in establishing and promoting ground breaking surgical methods for peripheral nerve accidents, these days declared the promotion of Peter J. Mariani to Govt Vice President and Main Financial Officer.

Mr. Mariani has served as Axogen’s Chief Fiscal Officer due to the fact 2016. For the duration of this time, he has played a critical job in the execution of Axogen’s system and in setting up the foundation for lengthy-time period expansion, overseeing a variety of initiatives that have strengthened the company’s cash composition, enhanced administration processes, and expanded the company’s services and capabilities.

“Pete’s management has experienced a significant impression on our organization around the past 5 yrs,” explained Karen Zaderej, chairman, CEO, and president of Axogen, Inc. “The means to comprehend the complete possible of our progress opportunity is pushed by continued willpower in our organization procedures, source allocation, and the execution of our vital strategic initiatives. This expanded purpose recognizes Pete’s considerable and ongoing contributions to Axogen’s expansion and supplies an opportunity for him to drive even more enhancements that guidance our capability to reach our mission.”

In his expanded function, Mr. Mariani will oversee the company’s Excellent Assurance workforce in addition to his existing organizational responsibilities, which include things like oversight of the Finance and Accounting, Investor Relations, Data Engineering, and Method Administration features.

About Axogen
Axogen (AXGN) is the primary business centered precisely on the science, progress, and commercialization of systems for peripheral nerve regeneration and fix. Axogen workforce are passionate about assisting to restore peripheral nerve function and excellent of daily life to people with physical hurt or transection to peripheral nerves by supplying revolutionary, clinically established, and economically effective fix solutions for surgeons and wellness treatment suppliers. Peripheral nerves offer the pathways for both of those motor and sensory alerts throughout the system. Every single day, people today go through traumatic accidents or undergo surgical processes that affect the operate of their peripheral nerves. Physical destruction to a peripheral nerve, or the inability to correctly reconnect peripheral nerves, can result in the decline of muscle or organ perform, the decline of sensory experience, or the initiation of agony.

Axogen’s system for peripheral nerve repair capabilities a comprehensive portfolio of products and solutions, like Avance^® Nerve Graft, a biologically energetic off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities related with a 2nd surgical internet site Axoguard Nerve Connector^®, a porcine submucosa extracellular matrix (ECM) coaptation assist for tensionless mend of severed peripheral nerves Axoguard Nerve Protector^®, a porcine submucosa ECM item used to wrap and guard weakened peripheral nerves and enhance the nerve reconstruction when stopping gentle tissue attachments Axoguard Nerve Cap^®, a porcine submucosa ECM product or service employed to safeguard a peripheral nerve conclusion and different the nerve from the bordering setting to minimize the progress of symptomatic or unpleasant neuroma and Avive^® Soft Tissue Membrane, a processed human umbilical twine intended for surgical use as a resorbable tender tissue barrier. The Axogen portfolio of products is obtainable in the United States, Canada, Germany, United Kingdom, Spain, South Korea, and several other nations around the world.

Cautionary Statements Regarding Ahead-Searching Statements
This press launch includes “forward-looking” statements as described in the Non-public Securities Litigation Reform Act of 1995. These statements are centered on management’s present anticipations or predictions of long term circumstances, situations, or final results dependent on many assumptions and management’s estimates of traits and financial variables in the markets in which we are energetic, as effectively as our business designs. Terms these types of as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “projects,” “forecasts,” “continue,” “may,” “should,” “will,” “goals,” and variants of these kinds of words and phrases and equivalent expressions are intended to establish these types of forward-on the lookout statements. The ahead-looking statements may possibly include things like, without having limitation, statements relevant to the envisioned affect of COVID-19 on our business enterprise, statements with regards to our growth, products progress, products potential, economical functionality, profits advancement, merchandise adoption, marketplace consciousness of our goods, knowledge validation, our assessment of our inside controls over monetary reporting, our visibility at and sponsorship of conferences and academic situations. The forward-seeking statements are and will be subject matter to challenges and uncertainties, which might cause real final results to vary materially from those expressed or implied in such ahead-hunting statements. Ahead-hunting statements contained in this push release must be evaluated with each other with the several uncertainties that impact our business enterprise and our marketplace, specially those people reviewed beneath Aspect I, Product 1A., “Risk Variables,” of our Once-a-year Report on Type 10-K, as amended on Form 10-K/A, for the fiscal year ended December 31, 2020, as perfectly as other challenges and cautionary statements established forth in our filings with the U.S. Securities and Trade Commission. Ahead-searching statements are not a warranty of upcoming overall performance, and true benefits may differ materially from individuals projected. The ahead-hunting statements are agent only as of the date they are made and, except as required by relevant regulation, we assume no accountability to publicly update or revise any ahead-searching statements, whether as a result of new information, potential functions, improved situations, or usually.

Speak to:
Axogen, Inc.
Peter J. Mariani, Main Economic Officer
[email protected]
[email protected]